Jason P Gardner

Author PubWeight™ 12.88^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	CD81 is an entry coreceptor for hepatitis C virus.	Proc Natl Acad Sci U S A	2004	3.01
2	Lapatinib versus hormone therapy in patients with advanced renal cell carcinoma: a randomized phase III clinical trial.	J Clin Oncol	2008	2.06
3	The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy.	Proc Natl Acad Sci U S A	2003	1.71
4	L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus.	Proc Natl Acad Sci U S A	2004	1.48
5	Comparison of two cancer vaccines targeting tyrosinase: plasmid DNA and recombinant alphavirus replicon particles.	Clin Cancer Res	2005	1.14
6	Human immunodeficiency virus type 1 attachment, coreceptor, and fusion inhibitors are active against both direct and trans infection of primary cells.	J Virol	2003	1.06
7	A novel alphavirus vaccine encoding prostate-specific membrane antigen elicits potent cellular and humoral immune responses.	Clin Cancer Res	2007	0.93
8	Expression of unmodified hepatitis C virus envelope glycoprotein-coding sequences leads to cryptic intron excision and cell surface expression of E1/E2 heterodimers comprising full-length and partially deleted E1.	J Virol	2003	0.90
9	L-SIGN (CD209L) isoforms differently mediate trans-infection of hepatoma cells by hepatitis C virus pseudoparticles.	J Gen Virol	2006	0.78